Penanggung Jawab Rektor Universitas Brawijaya Ketua Lembaga Penelitian Universitas Brawijaya
DEWAN REDAKSI
Ketua Prof. Dr. Ir. Syamsulbahri, MS
Anggota Prof. Dr. Ir. Moch. Munir, M.S (Unibraw-2008) Prof. Drs. Sutiman B. Sumitro, S.U. D. Sc (Unibraw-2008) Prof. Dr. Ir. SM Sitompul. (Unibraw-2008) Prof. Dr. Ir. Luqman Hakim, M.S (Unibraw-2008) Prof. Dr. Ir. Rustidja, M.S (Unibraw-2008) Dr. Ir. Nasir Saleh (Balitkabi Deptan-2008)
Penyunting Ahli Ir. Arifin Noor Sugiharto, M.Sc, PhD (Unibraw-2008) Ir. Didik Suprayogo, M.Sc., Ph.D (Unibraw-2008) Dr. Ir. Moch. Sahid (Balittas Deptan-2008) Brian O Flaherty (Ahli Bhs. lnggns-2008 Dra. Francien Herlen Tomasowa, Ph.D (Lab. Bhs. Unibraw-2008) Drs. Adiono, M.A., Ph.D (Lab. Bhs. Unibraw 2008)
Penyunting Pelaksana Drs. Sofy Permana, MSc, DSc. (Unibraw-2008) AgustinaTri Endharti, S.Si., Ph.D (Unibraw-2008)
Sekretariat Pujiono, SH
Alamat Redaksi/Penerbit Lembaga Penelitian Universitas Brawijaya Jalan Veteran, Malang-65145 Telp. (0341) 575824; 551611 psw. 301; Fak. (0341) 575828 E-mail
[email protected]
Deteksi Protein Spesifik CMV Pada Penderita Infark Miokard Akut (IMA) Yang Terinfeksi Cytomegalovirus (CMV) I.K.G.Muliarthab, Djanggan Sargowob,dan Adinda D.n.2) 1) Fakultas Kedokteran Universitas Brawijaya, Malang 2) Mahasiswa Program Studi Biomedik Pasca Sarjana Universitas Brawijaya, Malang Abstrak Diterima tanggal 12 April 2006 disetujui tanggal 15 Mei 2007
Tujuan penelitian ini, adalah membuktikan adanya protein spesifik dalam darah penderita Infark Miokard Akut (IMA) yang terinfeksi mikroorganisme, khususnya infeksi Penelitian deskriptif analitik crossectional ini menggunakan darah penderita IMA. Identifikasi protein spesifik yang terinfeksi oleh dilakukan dengan imunoblotting. Hasil penelitian menunjukkan bahwa (1) Kadar antibody anti pada penderita IMA lebih besar dibanding antibody terhadap pathogen lain seperti dan (2) CA/Kmempunyai antigen protein imunogenik 84Kd dan bereaksi dengan serum penderita IMA, sehingga kini berpotensi menyebabkan IMA. C
C
y
t
o
m
e
g
a
l
.
o
v
m
i
r
u
u
t
a
y
t
o
m
e
g
a
l
o
v
i
r
u
s
.
s
n
s
S
C
K
a
t
a
K
u
n
c
i
:
.
p
n
e
u
m
o
n
i
a
e
,
H
.
Protein spesifik
C
p
y
l
M
V
o
r
,
i
C
M
Infeksi
V
C
y
;
t
o
m
e
g
a
l
o
v
i
r
u
s
,
Infark Miokard Akut (IMA)
Ditection Spesific Protein Cytomegalovirus (CMV) On The Patient Of Infected AMI. Abstract Ditection spesific protein cytomegalovirus(CMV) on the patient of infected AMI. This study purposes to determine the specific protein in the blood of infected AMI patient in related to microbial infection, i.e. infection. This descriptive analytic crossectional study involves AMI patient. The identification of specific protein related to infection of cytomegalovirus was determined through immunoblotting with monoclonal antibody. The result showed that (1) antibody titer of anti were highest among the titer antibody of other pathogen, and (2) have an antigenic protein (84Kd) that is potential to cause AMI. C
y
t
o
m
e
g
a
l
o
v
i
r
u
s
.
S
m
u
t
a
n
C
K
e
s
M
C
p
n
e
u
m
o
n
i
a
e
,
H
.
p
y
V
y
:
w
.
o
r
d
s
Specific Protein
C
M
V
,
C
y
t
o
m
e
g
a
l
o
v
i
r
u
s
Infection, Acute Myocardial Infarction
l
o
r
i
,
C
M
V
;
DAFTAR PUSTAKA
Falk E., DhahP.K. and Valentine Fuster dalam Fuster V,Ross R., and Topol E.J., 1996, Pathogenesis of Plaque Disruption dalam Atheroschlerosis and Coronary Artery Disease, Philadelphia :Lippincot-Raven Publisher, 441-456. Fishbein MC, Siegel RJ., 1996, Hoe Big are CoronaryAtherosklerosis Plaques That Rapture ?,Circulation, 94:2662-2666. Fong IW., 2000, Emerging Relation between Infectious Disease and Coronary Artery Disease and Atherosklerosis, CMAJ: 163(1): 49-56. Fong IW., 2002, Infection and their role in Atheroschlerotic Vascular Disease, JADA, Vol. 133, June. Fortunato EA., Spector DH., 1999, Regulation of human cytomegalovirus gene expression, Adv. Virus Res., 54:61-127. Fuster V, Ross R., dalam Fuster V., Ross R., and Topol E.J.,1996, ThePathogenesis Atheroschlerosis, Philadelphia:Lippincot- Raven Publisher, 441-456
of
. Gattone M, 2001, C. Pneumoniae and CMV Seropositivity, Inflammatory Markers and The Risk of Myocardial Infarction at a Young Age, Am. Heart J., 142:633-640. e
t
a
l
.
,
Gaydos CA., Quinn TC, 2000, The Role of Chlamydia Pneumoniae in Cardiovascular Disease, Adv. Intern Med., 45: 139-73. Geng Y.J., and Libby, 2002, Progression of Atheroma, Arterioschlerosis, Trhrombosis and Vascular Biology, 22(9): 1370. Gupta S., 1997, Chronic Infection in Etiology of Pneumoniae, Clin. Cardiol (20): 829-836. e
t
a
l
,
Atherosklerosis the Case for Chlamydia
Harlow, E. and Lane, D., 1988, Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 553-612. KolA., Libby P., 1999, Molecular Mediators of Arterial Inflammation: A Role for Mikrobial Products?, Am.HeartJ., 138:S450-452. Lagrand KW., Visser CS., Hermens WT., Niessen HW, Verheught WA., Wolbink GJ., et al., 1999, CReactive as a Cardiovascular Risk Factor, Circulation, 100:96-102. Leinonen M., 2000, Chlamydia Pneumoniae and Other Risk Factor for Atherosklerosis, J. Infec. Dis., 18LS414-416. Lopez- Virella M., 2003, Triggers of Vascular Inflamatory Process in Arterioschlerosis, National Lipid Association. Matilla K.J, Valtonen W, Nieminen MS, Asikainen S., 1998, Role of Infection as a Risk Factor for Atherosclerosis, Myocardial Infarction, and Stroke, Clin. Infact. Dis., 26(3): 719-34. Melnick JL, Adam E, DeBakey ME., 1996, Cytomegalovirus and Atherosclerosis, Arch Immunol Ther Exp., 44(5-6): 297-302. Memon RA., Staprans I., Noor M., Holleran WM., UchidaY., Mazer AH.,etal., 2000, Infection and Inflammation Induce LDL Oxidation in Vivo, Arterioscler. Thromb. Vase. Biol., 20: 1526-1542.
Muhlestein JB., 2000, Chronic Infection and Coronary Artery Disease, Med. Clin. North Am., 84: 123-48. Nieto FJ., 1999, Viruses and Atherosclerosis: A Critical Review of The Epidemiologic Evidence, Asm. Heart J., 138: S453-458. Nieto FJ, Sorlie P, Comstock GW, 1997, Cytomegalovirus infection, lipoprotein (a), and hypercoagulability: an atherogenic link?, Artherioscler Thromb Vase Biol, 17(9): 1780-5. e
t
a
l
.
,
O'Connor S., Taylor C, Campbell LA., Epstein, Libby P., 2000, Potential Infectious Etiologies of Atherosclerosis: AMultifactorial Perspective, CDC Upcoming Issue, 7: 5. Perlmann, H. and Perlmann, P., 1994, Enzyme-Linked immunosorbent Assay. In: Cell Biology: A Laboratory Handbook. San Diego, CA, Academic Press, Inc., 322-328. Reinhardt B., 2002, Opinion Article: Cytomegalovirus is a Risk Factor in Atherogenesis, HERPES, 9:21-23. e
t
a
l
.
,
Rifai N., Ridker PM., 2001, High-Sensitivity C-Reactive Protein: A Novel and Promising Marker of Coronary Heart Disease, Clin. Chem., 47:403-411. Ross R., 1999, Atherosclerosis - An Inflammatory Disease (Review), In: Epstein HF (Eds), New England J. Medicine, 340:115-123. Ross R., Fuster V., 1996, The Pathogenesis of Atherosclerosis and Coronary Artery Disease, Philadelphia: Lippincott-Raven Publisher, 441-456. Shoenfeld Y., 2002, Infection in Atherosclerosis-Impact on Autoimmune Rheumatic Disease, Publisg by Center for Autoimmune Disease, Tel. Aviv University, Israel. Sorlie PD, Adam E, Melnick SL, 1994, Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC Study, J Med Virol, 42(1): 33-7. e
t
a
l
.
,
Span AH, Van Dam - Mieras MC, Muller W, Endert J, MullerAD, Bruggeman CA, 1991, The effect of virus infection on adherence of leukocytes or platelets to endothelial cells, Eir J Clin Invest, 21(3): 331-8. Speir E., Modali R.. Huang ES., Leon F., Shawl F., Finkel T, 1994, Potential role of human cytomegalovirus and p53 interaction in coronary restenosis, Science, 265: 391-394. e
t
a
l
.
,
Sterling JC, Kurtz JB., 1998, Viral Infections. In: Champion RH, Burton JL, Burns DA. Breathnach SM. Rook, Wilkinson, Ebling. Textbook of Dermatology Volume 2. 6th. Ed. Oxford: Blackwell Science, p.995-1000,1022-3. Zhou YF, Leon MB, Waclawiw MA, Popma JJ, Yu ZX, Finkel T, et al., 1996, Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy, N. Engl. J., 335:624-630.
